News
-
-
SHPA opioid surgery poll
Wednesday | May 16 2018THE Society of Hospital Pharmacists of Australia (SHPA) has launched the first "landscape survey" of hospital pharmacy practice for Australians post-surgery, as part of an effort to stem opioid misuse and abuse.
-
TWC vitamin supplier lists
Wednesday | May 16 2018TERRY White Chemmart will receive more than $10 million in marketing contributions for the Living Healthy complementary medicine brand over the next four years.
-
Respiratory biologic
Wednesday | May 16 2018THE Therapeutic Goods Administration (TGA) has approved Australia's first respiratory biologic medicine with an eight-week dosing schedule, following initiation with three doses administered every 4-weeks for severe eosinophilic asthma.
-
Enuresis resource
Wednesday | May 16 2018THE Agency for Clinical Innovation (ACI) has released a report addressing the need for children to have timely access to appropriate healthcare for the management of urinary incontinence.
-
NanaBis shipment
Wednesday | May 16 2018LISTED medicinal cannabis firm Medlab has delivered the first batch of its cannabis-based medicine NanaBis to Sydney's Royal North Shore Hospital ahead of human trials in advanced cancer pain.
-
AMS and pharmacists
Wednesday | May 16 2018THE publication released by the Australian Commission on Safety and Quality in Health Care titled Antimicrobial Stewardship In Australian Health Care 2018 summarises current evidence about antimicrobial stewardship (AMS) strategies and interventions and their implementation.
-
Med labels update
Wednesday | May 16 2018THE Therapeutic Goods Administration (TGA) has updated its guidance around the labelling of medicines.
-
Pharmacy pain mgt
Wednesday | May 16 2018COMMUNITY pharmacists' role in managing chronic pain is the subject of a new online course created by Guild Learning and Development in partnership with Mundipharma.
-
Mundicare for colds
Wednesday | May 16 2018MUNDIPHARMA has launched a new treatment for common colds which the company said had been shown in clinical trials to reduce the duration of the illness by up to two days.
